|
TABLE OF CONTENTS 1 INTRODUCTION 1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY 1.4 CURRENCY 1.5 STAKEHOLDERS 2 RESEARCH METHODOLOGY 2.1 MARKET SIZE ESTIMATION 2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 2.3 MARKET SHARE ESTIMATION
2.3.1 KEY DATA FROM SECONDARY SOURCES
2.3.2 KEY DATA FROM PRIMARY SOURCES
2.3.3 ASSUMPTIONS FOR THE STUDY 3 EXECUTIVE SUMMARY 4 PREMIUM INSIGHTS 4.1 LUCRATIVE OPPORTUNITIES IN THE GLOBAL GENOME EDITING MARKET 4.2 LIFE CYCLE ANALYSIS, BY REGION 5 MARKET OVERVIEW 5.1 INTRODUCTION 5.2 MARKET SEGMENTATION
5.2.1 BY APPLICATION
5.2.2 BY PRODUCT
5.2.3 BY END USER 5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Increased R&D expenditure and growth of the biotechnology and pharmaceutical industries
5.3.1.2 Increased funding for genomics research
5.3.1.3 Technological advancements
5.3.1.4 Increasing demand for synthetic genes
5.3.1.5 Global rise in production of genetically modified crops
5.3.2 RESTRAINTS
5.3.2.1 Stringent regulatory frameworks and time-consuming approval processes
5.3.2.2 Adverse public perception related to genetic research
5.3.3 OPPORTUNITY
5.3.3.1 Developing countries
5.3.4 CHALLENGE
5.3.4.1 Off-target effect of CRISPR 6 INDUSTRY INSIGHTS 6.1 INTRODUCTION 6.2 PORTER’S FIVE FORCES ANALYSIS
6.2.1 THREAT OF NEW ENTRANTS
6.2.2 THREAT OF SUBSTITUTES
6.2.3 BARGAINING POWER OF BUYERS
6.2.4 BARGAINING POWER OF SUPPLIERS
6.2.5 INTENSITY OF RIVALRY 6.3 STRATEGIC BENCHMARKING 6.4 SUPPLY CHAIN ANALYSIS
6.4.1 KEY INFLUENCERS 7 GENOME EDITING MARKET, BY APPLICATION 7.1 INTRODUCTION 7.2 CELL LINE ENGINEERING 7.3 ANIMAL GENETIC ENGINEERING 7.4 PLANT GENETIC ENGINEERING 7.5 OTHER APPLICATIONS 8 GENOME EDITING MARKET, BY TECHNOLOGY 8.1 INTRODUCTION 8.2 CRISPR 8.3 TALEN 8.4 ZFN 8.5 ANTISENSE TECHNOLOGY 8.6 OTHER TECHNOLOGIES 9 GENOME EDITING MARKET, BY END USER 9.1 INTRODUCTION 9.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 9.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 9.4 CONTRACT RESEARCH ORGANIZATIONS 10 GEOGRAPHIC ANALYSIS 10.1 INTRODUCTION 10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA 10.3 EUROPE 10.4 ASIA
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA (ROA) 10.5 REST OF THE WORLD (ROW) 11 COMPETITIVE LANDSCAPE 11.1 OVERVIEW 11.2 LEADING PLAYERS IN THE GENOME EDITING MARKET 11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
11.3.2 NEW PRODUCT AND SERVICE LAUNCHES
11.3.3 ACQUISITIONS
11.3.4 EXPANSIONS
11.3.5 OTHER DEVELOPMENTS 12 COMPANY PROFILES 12.1 INTRODUCTION 12.2 THERMO FISHER SCIENTIFIC, INC. 12.3 HORIZON DISCOVERY GROUP PLC 12.4 SIGMA-ALDRICH CORPORATION 12.5 GENSCRIPT USA INC. 12.6 SANGAMO BIOSCIENCES, INC. 12.7 INTEGRATED DNA TECHNOLOGIES, INC. 12.8 LONZA GROUP LTD. (SWITZERLAND) 12.9 NEW ENGLAND BIOLABS, INC. (U.S.) 12.10 ORIGENE TECHNOLOGIES, INC. (U.S.) 12.11 TRANSPOSAGEN BIOPHARMACEUTICALS, INC. (U.S.). 13 APPENDIX 13.1 INSIGHTS OF INDUSTRY EXPERTS 13.2 DISCUSSION GUIDE 13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 13.4 AVAILABLE CUSTOMIZATIONS 13.5 RELATED REPORTS
LIST OF TABLES
TABLE 1 GENOME EDITING MARKET SUMMARY
TABLE 2 RAPID GROWTH IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES IS DRIVING THE GENOME EDITING MARKET
TABLE 3 STRINGENT REGULATORY FRAMEWORKS AND ADVERSE PUBLIC PERCEPTION RELATED TO GENETIC RESEARCH RESTRAIN THE GROWTH OF THE GENOME EDITING MARKET
TABLE 4 DEVELOPING COUNTRIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES
TABLE 5 OFF-TARGET EFFECT OF CRISPR IS A MAJOR CHALLENGE FOR MARKET PLAYERS
TABLE 6 MARKET DEVELOPMENTS BETWEEN 2011 AND 2014
TABLE 7 GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 8 GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING, BY REGION, 2012–2019 ($MILLION)
TABLE 9 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 10 ASIA: GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 11 GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING, BY REGION, 2012–2019 ($MILLION)
TABLE 12 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 13 ASIA: GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 14 GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING, BY REGION, 2012-2019 ($MILLION)
TABLE 15 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 16 ASIA: GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING, BY REGION, 2012–2019 ($MILLION)
TABLE 17 GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2012-2019 ($MILLION)
TABLE 18 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 19 ASIA: GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 20 GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 21 CRISPR-BASED GENOME EDITING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 22 NORTH AMERICA: CRISPR-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 23 ASIA: CRISPR-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 24 TALEN-BASED GENOME EDITING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 25 NORTH AMERICA: TALEN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 26 ASIA: TALEN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 27 ZFN-BASED GENOME EDITING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 28 NORTH AMERICA: ZFN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 29 ASIA: ZFN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 30 ANTISENSE TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 31 NORTH AMERICA: ANTISENSE-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 32 ASIA: ANTISENSE-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 33 OTHER TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 34 NORTH AMERICA: OTHER TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 35 ASIA: OTHER TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 36 GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 37 GLOBAL GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2012–2019 ($MILLION)
TABLE 38 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 39 ASIA: GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 40 GLOBAL GENOME EDITING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2012–2019 ($MILLION)
TABLE 41 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 42 ASIA: GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 43 GLOBAL GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2012–2019 ($MILLION)
TABLE 44 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 45 ASIA: GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 46 GENOME EDITING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 47 NORTH AMERICA: GENOME EDITING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 48 NORTH AMERICA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 49 NORTH AMERICA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 50 NORTH AMERICA: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 51 U.S.: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 52 U.S.: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 53 U.S.: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 54 CANADA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 55 CANADA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 56 CANADA: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 57 EUROPE: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 58 EUROPE: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 59 EUROPE: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 60 ASIA: GENOME EDITING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 61 ASIA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 62 ASIA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 63 ASIA: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 64 JAPAN: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 65 JAPAN: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 66 JAPAN: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 67 CHINA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 68 CHINA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 69 CHINA: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 70 INDIA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 71 INDIA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 72 INDIA: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 73 ROA: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 74 ROA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 75 ROA: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 76 ROW: GENOME EDITING MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 77 ROW: GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 78 ROW: GENOME EDITING MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 79 RANK OF COMPANIES IN THE GLOBAL GENOME EDITING MARKET, 2014
TABLE 80 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012–2015
TABLE 81 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012–2015
TABLE 82 NEW PRODUCT AND SERVICE LAUNCHES, 2012–2015
TABLE 83 NEW PRODUCT AND SERVICE LAUNCHES, 2012–2015
TABLE 84 ACQUISITIONS, 2012–2015
TABLE 85 ACQUISITIONS, 2012–2015
TABLE 86 EXPANSIONS, 2012–2015
TABLE 87 EXPANSIONS, 2012–2015
TABLE 88 OTHER DEVELOPMENTS, 2012–2015
TABLE 89 OTHER DEVELOPMENTS, 2012–2015
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 GENOME EDITING MARKET SIZE, BY APPLICATION, 2014 VS. 2019 ($MILLION)
FIGURE 7 GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014 VS. 2019 ($MILLION)
FIGURE 8 GENOME EDITING MARKET SIZE, BY END USER, 2014 VS. 2019 ($MILLION)
FIGURE 9 GENOME EDITING MARKET SIZE, BY REGION, 2014 VS. 2019 ($MILLION)
FIGURE 10 INCREASE IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES WILL DRIVE MARKET GROWTH
FIGURE 11 ANIMAL GENETIC ENGINEERING APPLICATION SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2014
FIGURE 12 ASIAN MARKET TO EXPERIENCE FASTEST GROWTH IN THE FORECAST PERIOD (2014 TO 2019)
FIGURE 13 ASIA POISED FOR LUCRATIVE GROWTH
FIGURE 14 GENOME EDITING MARKET SEGMENTATION: BY APPLICATION
FIGURE 15 GENOME EDITING MARKET SEGMENTATION: BY TECHNOLOGY
FIGURE 16 GENOME EDITING MARKET SEGMENTATION: BY END USER
FIGURE 17 GROWTH IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES WILL DRIVE THE GENOME EDITING MARKET
FIGURE 18 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
FIGURE 19 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
FIGURE 20 GENOME EDITING MARKET SEGMENTATION, BY APPLICATION
FIGURE 21 CELL LINE ENGINEERING APPLICATION SEGMENT DOMINATES THE MARKET
FIGURE 22 CELL LINE ENGINEERING TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD
FIGURE 23 NORTH AMERICA DOMINATED THE ANIMAL GENETIC ENGINEERING APPLICATION SEGMENT IN 2014
FIGURE 24 GROWING TREND OF GM CROPS IN THE U.S.
FIGURE 25 ASIA TO WITNESS HIGHEST GROWTH IN THE PLANT GENETIC ENGINEERING APPLICATION SEGMENT
FIGURE 26 ASIA TO WITNESS HIGHEST GROWTH IN THE OTHER APPLICATIONS SEGMENT BY 2019
FIGURE 27 GENOME EDITING MARKET SEGMENTATION, BY TECHNOLOGY
FIGURE 28 GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2014 VS. 2019 ($MILLION)
FIGURE 29 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE CRISPR SEGMENT IN 2019
FIGURE 30 NORTH AMERICA TO DOMINATE THE TALEN SEGMENT IN 2019
FIGURE 31 ASIA WILL BE THE FASTEST-GROWING REGIONAL SEGMENT FOR ZFN IN 2019
FIGURE 32 NORTH AMERICA WAS THE BIGGEST MARKET FOR ANTISENSE TECHNOLOGY IN 2014
FIGURE 33 ASIA WILL BE THE FASTEST-GROWING MARKET FOR OTHER TECHNOLOGIES BETWEEN 2014 AND 2019
FIGURE 34 GENOME EDITING MARKET SEGMENTATION, BY END USER
FIGURE 35 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES WERE THE LARGEST END-USER SEGMENT IN 2014
FIGURE 36 NUMBER OF BIOTECHNOLOGY AND PHARMACEUTICAL PATENTS GRANTED IN 2012, BY REGION
FIGURE 37 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES END-USER SEGMENT TO WITNESS THE HIGHEST GROWTH IN ASIA
FIGURE 38 PUBLIC-SECTOR RESEARCH FUNDING IS DRIVING THE GROWTH OF THE ACADEMIC & GOVERNMENT RESEARCH INSTITUTES SEGMENT
FIGURE 39 NORTH AMERICA DOMINATED THE GENOME EDITING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES IN 2014
FIGURE 40 ASIA TO WITNESS THE HIGHEST GROWTH IN THE GENOME EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS
FIGURE 41 GENOME EDITING MARKET SEGMENTATION, BY REGION
FIGURE 42 GENOME EDITING MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2014–2019
FIGURE 43 GENOME EDITING MARKET IN ASIA EXPECTED TO GROW AT THE HIGHEST RATE FROM 2014 TO 2019
FIGURE 44 NORTH AMERICA: MARKET SNAPSHOT
FIGURE 45 GENOME EDITING MARKET IN CANADA TO GROW AT HIGHEST RATE FROM 2014 TO 2019
FIGURE 46 CELL LINE ENGINEERING HELD THE LARGEST SHARE OF THE GENOME EDITING MARKET IN NORTH AMERICA IN 2014
FIGURE 47 CRISPR FORMED THE LARGEST TECHNOLOGY SEGMENT IN NORTH AMERICA FROM 2014 TO 2019
FIGURE 48 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES FORMED THE LARGEST END-USER SEGMENT IN NORTH AMERICA IN 2014
FIGURE 49 CELL LINE ENGINEERING FORMED THE LARGEST APPLICATION SEGMENT IN THE U.S.IN 2014
FIGURE 50 CRISPR TECHNOLOGY SEGMENT HELD THE LARGEST SHARE IN THE U.S. MARKET IN 2014
FIGURE 51 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES SEGMENT DOMINATED THE U.S. MARKETIN 2014
FIGURE 52 CELL LINE ENGINEERING HELD THE LARGEST SHARE IN THE GENOME EDITING APPLICATIONS MARKET IN CANADA IN 2014
FIGURE 53 CRISPR FORMED THE LARGEST TECHNOLOGY SEGMENT IN CANADA IN 2014
FIGURE 54 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES FORMED THE LARGEST END-USER SEGMENT IN CANADA IN 2014
FIGURE 55 CELL LINE ENGINEERING ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING APPLICATIONS MARKET IN EUROPE
FIGURE 56 CRISPR FORMED THE LARGEST TECHNOLOGY SEGMENT IN EUROPE IN 2014
FIGURE 57 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING MARKET IN EUROPE
FIGURE 58 ASIA: MARKET SNAPSHOT
FIGURE 59 GENOME EDITING MARKET IN CHINA TO GROW AT HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 60 CELL LINE ENGINEERING SEGMENT DOMINATED THE GENOME EDITING APPLICATIONS MARKET IN ASIA IN 2014
FIGURE 61 CRISPR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING TECHNOLOGIES MARKET IN ASIA
FIGURE 62 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING MARKET IN ASIA
FIGURE 63 CELL LINE ENGINEERING FORMED THE LARGEST APPLICATION SEGMENT IN JAPAN IN 2014
FIGURE 64 CRISPR TECHNOLOGY SEGMENT HELD THE LARGEST SHARE OF THE MARKET IN JAPAN IN 2014
FIGURE 65 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING END-USERS MARKET IN JAPAN
FIGURE 66 CELL LINE ENGINEERING WAS THE LARGEST APPLICATION SEGMENT IN CHINA IN 2014
FIGURE 67 CRISPR HELD THE LARGEST SHARE OF THE MARKET IN CHINA IN 2014
FIGURE 68 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING MARKET IN CHINA
FIGURE 69 CELL LINE ENGINEERING FORMED THE LARGEST APPLICATION SEGMENT IN INDIA
FIGURE 70 CRISPR FORMED THE LARGEST AND THE FASTEST-GROWING TECHNOLOGY SEGMENT IN INDIA IN 2014
FIGURE 71 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES FORMED THE LARGEST END-USER SEGMENT IN INDIA IN 2014
FIGURE 72 CELL LINE ENGINEERING COMMANDED THE LARGEST SHARE OF THE ROA GENOME EDITING MARKET IN 2014
FIGURE 73 CRISPR TECHNOLOGY SEGMENT DOMINATED THE ROA MARKET FOR GENOME EDITING IN 2014
FIGURE 74 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES SEGMENT DOMINATE THE ROA MARKET FOR GENOME EDITING IN 2014
FIGURE 75 CELL LINE ENGINEERING COMMANDED THE LARGEST SHARE OF THE ROW GENOME EDITING APPLICATIONS MARKET IN 2014
FIGURE 76 CRISPR WERE THE LARGEST TECHNOLOGY SEGMENT IN 2014
FIGURE 77 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES SEGMENT DOMINATE THE ROW MARKET FOR GENOME EDITING IN 2014
FIGURE 78 PLAYERS ADOPTED AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS AS THEIR KEY STRATEGY BETWEEN 2012 AND 2015
FIGURE 79 BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WAS THE KEY STRATEGY
FIGURE 80 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
FIGURE 81 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 82 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
FIGURE 83 SANGAMO BIOSCIENCES, INC.: COMPANY SNAPSHOT
FIGURE 84 LONZA GROUP LTD.: COMPANY SNAPSHOT
|
현재위치 : 
